Vitespen Terminated Phase 3 Trials for Renal Cancers / Renal Cell Adenocarcinoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00126178Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer